From the guest editor: Triple-negative breast cancer.
作者信息
Hudis Clifford A
出版信息
Cancer J. 2010 Jan-Feb;16(1):10-1. doi: 10.1097/PPO.0b013e3181d388ca.
PMID:20164684
Abstract
摘要
相似文献
1
From the guest editor: Triple-negative breast cancer.
Cancer J. 2010 Jan-Feb;16(1):10-1. doi: 10.1097/PPO.0b013e3181d388ca.
2
New approaches for triple-negative breast cancer.
Oncology (Williston Park). 2012 Oct;26(10):916, 931, 935.
3
Triple-negative breast cancer.
Oncology (Williston Park). 2010 Oct;24(10 Suppl):40a.
4
Are triple-negative and basal-like breast cancer synonymous?
Clin Cancer Res. 2008 Jan 15;14(2):618; author reply 618-9. doi: 10.1158/1078-0432.CCR-07-1943.
5
Triple-negative breast cancer and brain metastases.
Clin Oncol (R Coll Radiol). 2010 Feb;22(1):84. doi: 10.1016/j.clon.2009.08.010. Epub 2009 Sep 13.
6
Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?
Cancer J. 2010 Jan-Feb;16(1):23-32. doi: 10.1097/PPO.0b013e3181d24fc1.
7
Estrogen receptor-beta status influences clinical outcome of triple-negative breast cancer.
Breast Cancer. 2009;16(4):281-2. doi: 10.1007/s12282-009-0110-3. Epub 2009 Apr 22.
8
An unusual triple-negative breast carcinoma.
Histopathology. 2009 Sep;55(3):364-6. doi: 10.1111/j.1365-2559.2009.03349.x.
9
What is triple-negative breast cancer?
Eur J Cancer. 2008 Dec;44(18):2799-805. doi: 10.1016/j.ejca.2008.09.034. Epub 2008 Nov 12.
10
Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
Expert Rev Anticancer Ther. 2010 Feb;10(2):199-207. doi: 10.1586/era.09.189.
引用本文的文献
1
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies.
Mol Endocrinol. 2011 Feb;25(2):199-211. doi: 10.1210/me.2010-0164. Epub 2010 Sep 22.
Zotero 插件